Experimental CAR T-Cell therapy takes on relapsed leukemia
Disease control
Recruiting now
This study tests an experimental treatment called GYA01 (CART84) for people with acute myeloid leukemia (AML) or T-cell acute lymphoblastic leukemia (T-ALL) that has returned or not responded to standard therapy. The treatment uses a patient's own immune cells, modified in a lab …
Phase: PHASE1, PHASE2 • Sponsor: Gyala Therapeutics • Aim: Disease control
Last updated Apr 30, 2026 15:49 UTC